Logo image of Z

ZILLOW GROUP INC - C (Z) Stock Fundamental Analysis

NASDAQ:Z - US98954M2008 - Common Stock

84.31 USD
-0.99 (-1.16%)
Last: 8/29/2025, 8:00:44 PM
85.0826 USD
+0.77 (+0.92%)
After Hours: 8/29/2025, 8:00:44 PM
Fundamental Rating

5

Z gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. While Z has a great health rating, there are worries on its profitability. Z is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

Z had positive earnings in the past year.
Z had a positive operating cash flow in the past year.
Z had negative earnings in each of the past 5 years.
Z had a positive operating cash flow in 4 of the past 5 years.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

Z has a Return On Assets (-1.14%) which is comparable to the rest of the industry.
Z has a Return On Equity of -1.31%. This is comparable to the rest of the industry: Z outperforms 58.73% of its industry peers.
Industry RankSector Rank
ROA -1.14%
ROE -1.31%
ROIC N/A
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

Z has a better Gross Margin (75.75%) than 88.89% of its industry peers.
Z's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for Z so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 75.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
Z has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, Z has more shares outstanding
Compared to 1 year ago, Z has an improved debt to assets ratio.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 18.67 indicates that Z is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 18.67, Z belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Z has a debt to FCF ratio of 1.07. This is a very positive value and a sign of high solvency as it would only need 1.07 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.07, Z belongs to the top of the industry, outperforming 84.13% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that Z is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.05, Z belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.07
Altman-Z 18.67
ROIC/WACCN/A
WACC8.52%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

2.3 Liquidity

A Current Ratio of 3.34 indicates that Z has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.34, Z is doing good in the industry, outperforming 74.60% of the companies in the same industry.
Z has a Quick Ratio of 3.34. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
Z has a better Quick ratio (3.34) than 79.37% of its industry peers.
Industry RankSector Rank
Current Ratio 3.34
Quick Ratio 3.34
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

Z shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.72%, which is quite good.
The Revenue has grown by 15.31% in the past year. This is quite good.
Measured over the past years, Z shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)11.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.56%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%14.51%

3.2 Future

Z is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.71% yearly.
Z is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.05% yearly.
EPS Next Y21.54%
EPS Next 2Y29.5%
EPS Next 3Y32.37%
EPS Next 5Y33.71%
Revenue Next Year15.32%
Revenue Next 2Y14.99%
Revenue Next 3Y14.97%
Revenue Next 5Y15.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 58.96, Z can be considered very expensive at the moment.
Z's Price/Earnings ratio is a bit cheaper when compared to the industry. Z is cheaper than 65.08% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.08. Z is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 36.70, the valuation of Z can be described as expensive.
Based on the Price/Forward Earnings ratio, Z is valued a bit cheaper than the industry average as 73.02% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of Z to the average of the S&P500 Index (22.72), we can say Z is valued expensively.
Industry RankSector Rank
PE 58.96
Fwd PE 36.7
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as Z.
Z's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 95
EV/EBITDA 143.46
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as Z's earnings are expected to grow with 32.37% in the coming years.
PEG (NY)2.74
PEG (5Y)N/A
EPS Next 2Y29.5%
EPS Next 3Y32.37%

0

5. Dividend

5.1 Amount

No dividends for Z!.
Industry RankSector Rank
Dividend Yield N/A

ZILLOW GROUP INC - C

NASDAQ:Z (8/29/2025, 8:00:44 PM)

After market: 85.0826 +0.77 (+0.92%)

84.31

-0.99 (-1.16%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners95.52%
Inst Owner Change1.23%
Ins Owners6.74%
Ins Owner Change7.29%
Market Cap20.43B
Analysts72.67
Price Target90.4 (7.22%)
Short Float %8.21%
Short Ratio5.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.6%
Min EPS beat(2)-7.26%
Max EPS beat(2)8.47%
EPS beat(4)2
Avg EPS beat(4)3.07%
Min EPS beat(4)-7.26%
Max EPS beat(4)18.32%
EPS beat(8)6
Avg EPS beat(8)22.01%
EPS beat(12)10
Avg EPS beat(12)78.63%
EPS beat(16)13
Avg EPS beat(16)27.51%
Revenue beat(2)0
Avg Revenue beat(2)-0.54%
Min Revenue beat(2)-0.78%
Max Revenue beat(2)-0.3%
Revenue beat(4)1
Avg Revenue beat(4)0.3%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)2.69%
Revenue beat(8)5
Avg Revenue beat(8)1.46%
Revenue beat(12)9
Avg Revenue beat(12)2.61%
Revenue beat(16)10
Avg Revenue beat(16)-10.95%
PT rev (1m)9.49%
PT rev (3m)3.44%
EPS NQ rev (1m)-4.42%
EPS NQ rev (3m)-13.18%
EPS NY rev (1m)-2.91%
EPS NY rev (3m)-2.68%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)-0.19%
Revenue NY rev (1m)0.5%
Revenue NY rev (3m)0.38%
Valuation
Industry RankSector Rank
PE 58.96
Fwd PE 36.7
P/S 8.55
P/FCF 95
P/OCF 42.2
P/B 4.3
P/tB 12.47
EV/EBITDA 143.46
EPS(TTM)1.43
EY1.7%
EPS(NY)2.3
Fwd EY2.73%
FCF(TTM)0.89
FCFY1.05%
OCF(TTM)2
OCFY2.37%
SpS9.86
BVpS19.59
TBVpS6.76
PEG (NY)2.74
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.14%
ROE -1.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 75.75%
FCFM 9%
ROA(3y)-1.95%
ROA(5y)-2.59%
ROE(3y)-2.68%
ROE(5y)-4.27%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y42.3%
GM growth 5Y9.85%
F-Score7
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 1.07
Debt/EBITDA 1.74
Cap/Depr 101.51%
Cap/Sales 11.26%
Interest Coverage N/A
Cash Conversion 366.67%
Profit Quality N/A
Current Ratio 3.34
Quick Ratio 3.34
Altman-Z 18.67
F-Score7
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)73.5%
Cap/Depr(5y)73.95%
Cap/Sales(3y)7.76%
Cap/Sales(5y)5.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.56%
EPS Next Y21.54%
EPS Next 2Y29.5%
EPS Next 3Y32.37%
EPS Next 5Y33.71%
Revenue 1Y (TTM)15.31%
Revenue growth 3Y-35.01%
Revenue growth 5Y-4%
Sales Q2Q%14.51%
Revenue Next Year15.32%
Revenue Next 2Y14.99%
Revenue Next 3Y14.97%
Revenue Next 5Y15.05%
EBIT growth 1Y39.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year430.12%
EBIT Next 3Y96.41%
EBIT Next 5Y60.65%
FCF growth 1Y-25.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.5%
OCF growth 3YN/A
OCF growth 5YN/A